H c mahler (8 risultati)

Soft cover. Condizione: Very Good. 100 pages. F R Leavis "Education and the University: (III) Literary Studies" / R C Knight "The Politeness of Racine" / D W Harding "The Theme of 'The Ancient Mariner'" / W H Mellers "Mahler as Key-Figure" / D A Traversi "Henry the Fifth" / T R Barnes "Poets in Wartime" / Martin Turnell "Proust" / J C Maxwell "Essays on Culture and Civilisation" / Eric Blom "Musical Conditions in the XVIIIth Century".…

Hardcover. Condizione: Fine. Condizione sovraccoperta: Very Good. 1st American Abridged edition ; 216 pp. ; illustrated ; 22 cm. ; ISBN: 0025678302 :; 9780025678309 LCCN: 74-22052 ; LC: ML410.B4; Dewey: 780/.92/4 ; OCLC: 1085709 ; brown cloth with gold lettering, in color pictorial dustjacket ; "This extensive review of Beethoven's life and career combines illustrations and documents to give a comprehensive and vivid view of Beethoven's background, the world in which he lived, his friends and patrons, his fellow musicians, the women he loved, the places he visited. Recent research in connection with the two hundredth anniversary of the composer's birth (1970) uncovered a large number of hitherto unpublished and, in some cases, unknown paintings, [and] among the portraits and prints reproduced are some not previously published in color. The documents include copious extracts from Beethoven's letters and conversation books, as well as paper notices, related closely to the illustrations, they provide a commentary on Beethoven's personality and appearance, his piano-playing, conducting and musical ideas. There are also reproductions of his scores, in autograph and first edition."--dustjacket ; slight foxing ; owner stamp on front endpaper ; slight wear to dustjacket, else FINE/VG. Book. …

tapa dura. Condizione: Bien. Literatura.(82) El diario de la novia ; El amuleto de la Raní Juventud. Barcelona. 1924. 20 cm. 2 obras en 1 tomo. Encuadernación en tapa dura artesanal. En lomo: 860 . Pegatina en lomo . (=2140441=) LR216.

Buch. Condizione: Neu. Neuware - This book describes how to address the analysis of aggregates and particles in protein pharmaceuticals, provides a comprehensive overview of current methods and integrated approaches used to quantify and characterize aggregates and particles, and discusses regulatory requirements. Analytical methods covered in the book include separation, light scattering, microscopy, and spectroscopy. Enables researchers to better detect, measure, and characterize aggregates and particles during protein drug developmentFeaturing contributions from leading pharmaceutical investigators around the world, this text enables researchers to choose the most appropriate analytical methods in order to detect and characterize the full spectrum of protein aggregates and particles that can be present in a protein pharmaceutical. Moreover, the authors provide detailed examples of how these methods can be applied during both process and formulation development, helping researchers better manage the problem of protein instability as they seek to develop protein drugs.The text begins with an introduction to aggregates and particles, focusing on their potential immunogenicity. Next, it covers:Methods to detect and measure soluble aggregates based on separation, light scattering, and new technologyMethods to detect and measure insoluble aggregates and both sub-visible and visible particlesSpectroscopic techniques such as UV/VIS, fluorescence, infrared and Raman spectroscopy, and microscopy to characterize aggregates and particles, elucidate their structures, and identify proteinaceous and non-proteinaceous particlesComparative advantages and disadvantages of the methods for protein aggregate analysisApproaches for managing aggregates and particles found during protein purification and formulation developmentThroughout the text, case studies help researchers deal with the challenges that arise in detecting and analyzing protein aggregates and particles.Protein pharmaceuticals are increasingly used to treat life-threatening and chronic diseases, including cancer, viral infections, metabolic disorders, and central nervous system diseases. With Analysis of Aggregates and Particles in Protein Pharmaceuticals as their guide, pharmaceutical researchers now have an important tool in overcoming the challenging problem of aggregates and particles in protein drug development.…

Buch. Condizione: Neu. Analysis of Aggregates and Particles in Protein Pharmaceuticals | H-C Mahler | Buch | Contributors ixPreface xiiiGlossary xv1 The Critical Need for Robust Assays for Quantitation and Characterization of Aggregates of Therapeutic Proteins 1John F. Carpenter | Englisch | 2012 | John Wiley & Sons Inc | EAN 9780470497180 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu.…

Couverture souple. Condizione: Comme neuf. Edition originale. Beyrouth 2017. 1 Volume/1. --- Comme Neuf -- Broché collé. Format in-8°( 23,5 x 15,5 cm )(.500 gr ). ------- 221 pages avec 37 figures en N&B. ************************** Présentation éditeur : "" Ce second volume consacré aux sources de l histoire de Tyr poursuit l enquête sur la grande ville portuaire aux époques antique et médiévale, pendant plus de seize siècles, d Alexandre le Grand aux Mamelouks. La documentation écrite, abondante et variée, s étend des inscriptions aux sceaux, des romans grecs aux manuscrits arabes. Confrontée aux apports de l archéologie aérienne, de l étude des amphores ou des résultats des fouilles, elle éclaire des pans entiers de l histoire économique et politique, mais aussi de la topographie de l ancienne cité phénicienne. Ces documents sont ici présentés et étudiés par Julien Aliquot, Patricia Antaki-Masson, Pascal Arnaud, Michel Balard, Krijnie Ciggaar, Jean-Claude Cheynet, Jean-Charles Ducène, Pierre-Louis Gatier, Karl-Uwe Mahler, Marie-Adélaïde Nielen, Lévon Nordiguian, Dominique Pieri et Cécile Treffort. "" *********************** SOMMAIRE : Antiquité : J. Aliquot, Les Tyriens parlent aux Delphiens P.-L.Gatier et D. Pieri, Les vins de Tyr et de Sarepta dans l'Antiquité K.-U. Mahler, Marble Sculptures from Tyre in European Collections J. Aliquot, La dédicace de Lepcis Magna à Tyr et les images de la ville antique P. Arnaud, Marin de Tyr J.-Cl. Cheynet, Les sceaux byzantins, sources de l'histoire de Tyr. Moyen Âge : J.-Ch. Ducène, Tyr chez les géographes arabes et orientaux C. Treffort, Une nouvelle inscription d'époque franque découverte à Tyr M.-A. Nielen, Les sceaux seigneuriaux de Terre Sainte, modèle pour l'Occident ? L'exemple de Tyr M. Balard, Sources génoises pour l'histoire de Tyr au Moyen Âge K. Ciggaar, La chapelle du château de Tyr Annexe : L. Nordiguian, P. Antaki-Masson, Tyr dans les archives photographiques du P. Antoine Poidebard Index par J. Aliquot .************** Ref 569.…

Paperback. Condizione: Good. First Edition. 68 pages. Features: Cover illustration of Quantico, with photos of Camp Barrett, Breckinridge Hall, Geiger Hall, Butler Stadioum and Lejeune Hall inside front cover; Archibald Henderson & the Fighting Indians; Troop Tests - How They Work; Two-page illustrated ad for the Vertol 107 helicopter; Our War Problems - An Amphibious Answer; Defense in the Summary Court; Commando Carrier - HMS Bulwark, Britain's first LPH is now on station in the Far East; Daniel Joseph Daly - Reluctant Hero; A Prayer for Marines; Martcom Report (part 1 of 2); Russian Attack Aviation - the Russians didn't invent close air support but they've been at it since WWII - with these results; Report from the Ready Forces - FMF LANT - Combat Readiness and Programs to Improve Readiness; Introduction to EOD; The Salty Skipper; OJR (On the Job Retirement) Blues; Competition Makes Marines; The Marine Reserve; Modern War Gaming - State of the Art; Transfers and Promotions; and more. Average wear. Unmarked. A sound vintage copy. Size: 4to - over 9¾" - 12" tall. Corriero, Guy (cover) (illustratore). Magazine.…

Geheftet. Condizione: New. Biopharmazeutika gewinnen trotz aller Rueckschlaege bei den Neuzulassungen zunehmend an Bedeutung. Im Jahr 2012 waren bereits 21% aller verkauften Medikamente Biopharmazeutika. Aber gerade bei diesen Produkten, die den Schwankungen und Risiken biologischer Sy.